Evidence map›Paper›PMID 31867113›Full record

ArticleJournal of pharmaceutical policy and practice2019

The association of HIV and easy access to narcotics in Pakistan; calling drug policy makers.

Tauqeer Hussain Mallhi, Yusra Habib Khan, Amjad Khan, Nasser Hadal Alotaibi, Abdulaziz Ibrahim Alzarea, Furqan Khurshid Hashmi

Abstract read
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tauqeer Hussain Mallhi1Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka, Al-Jouf Kingdom of Saudi Arabia.ORCID 0000-0001-9957-5362
Yusra Habib Khan1Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka, Al-Jouf Kingdom of Saudi Arabia.
Amjad Khan2Department of Pharmacy, Quaid-i-Azam University, Islamabad, 45320 Pakistan.
Nasser Hadal Alotaibi1Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka, Al-Jouf Kingdom of Saudi Arabia.
Abdulaziz Ibrahim Alzarea1Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka, Al-Jouf Kingdom of Saudi Arabia.
Furqan Khurshid Hashmi3University College of Pharmacy, University of the Punjab, Allama Iqbal Campus, Lahore, 54000 Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HIV in Pakistan is concentrated to people who inject drugs (PWID) and easy accessibility of narcotics to this population cannot be disregarded as a risk factor of growing encumbrance of AIDS in the country. All the narcotics and other medications having high potential of abuse are stratified into Schedule G of Punjab Drug Rules 2017. According to these rules, drugs in Schedule G shall be sold in pharmacy under the direct supervision of qualified pharmacist. However, Schedule G is not implemented in Punjab due to continuous resistance from pharmaceutical stakeholders including medical store owners (who are barred to sell drugs from schedule G). Since 1.6 million PWID reported misuse of prescription opioids for non-medical use, delayed implementation of schedule G is attributing to the unabated sale of narcotics without prescription and for non-medical purposes, which is further contributing to the staggering number of PWID in the country. Implementing schedule G will not only curb the existing situation of HIV but will also mitigate the contribution of PWID towards the future events.

Indexed as

Drug actDrug policyHIVNarcotics abusePakistanPWIDSchedule G

Identifiers

PMID31867113
PMCPMC6918682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.